Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Neil Lesser
Title
Principal, Deloitte Consulting LLP
Bio
Neil Lesser is a Principal with Deloitte and he leads Deloitte’s Life Sciences Research & Development practice. In this role, he leads a team focused on the entire biopharma and medical technology R&D value chain, including capabilities and offerings that span from strategy through technology transformation.
Neil has been with Deloitte since 1998 and has extensive experience advising and partnering with biopharma R&D executives on portfolio and capability strategy, capital allocation choices, R&D productivity improvement initiatives, and large operating model and organization transformations.
Neil is a frequent writer and speaker on Life Sciences R&D strategy and productivity topics. He is a co-author of Deloitte’s annual study that measures Life Sciences R&D return on investment and productivity, which has been featured in The Economist, Financial Times, The Wall Street Journal, Forbes and many other national and trade publications.
Neil has been with Deloitte since 1998 and has extensive experience advising and partnering with biopharma R&D executives on portfolio and capability strategy, capital allocation choices, R&D productivity improvement initiatives, and large operating model and organization transformations.
Neil is a frequent writer and speaker on Life Sciences R&D strategy and productivity topics. He is a co-author of Deloitte’s annual study that measures Life Sciences R&D return on investment and productivity, which has been featured in The Economist, Financial Times, The Wall Street Journal, Forbes and many other national and trade publications.
